{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T03:39:09Z","timestamp":1789184349242,"version":"build-2803163510"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"crossref","award":["2023J01602"],"award-info":[{"award-number":["2023J01602"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-21387-7","type":"journal-article","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T14:01:54Z","timestamp":1761573714000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Development and validation of a prognostic nomogram for overall survival in individuals with malignant meningiomas: a population-based study"],"prefix":"10.1038","volume":"15","author":[{"given":"Hongliang","family":"Ge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajun","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinye","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dengliang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zanyi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dezhi","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,27]]},"reference":[{"key":"21387_CR1","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/noaa200","volume":"22","author":"QT Ostrom","year":"2020","unstructured":"Ostrom, Q. T. et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2013\u20132017. Neuro Oncol. 22, iv1\u2013iv96 (2020).","journal-title":"Neuro Oncol."},{"key":"21387_CR2","doi-asserted-by":"publisher","first-page":"v1","DOI":"10.1093\/neuonc\/now207","volume":"18","author":"QT Ostrom","year":"2016","unstructured":"Ostrom, Q. T. et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the united States in 2009\u20132013. Neuro Oncol. 18, v1\u2013v75 (2016).","journal-title":"Neuro Oncol."},{"key":"21387_CR3","doi-asserted-by":"crossref","unstructured":"Buerki, R. A., Horbinski, C. M., Kruser, T.,  Horowitz, P. M., James, C.D. & Lukas, R.V. An overview of meningiomas. Future Oncol. 14, 2161\u20132177 (2018).","DOI":"10.2217\/fon-2018-0006"},{"key":"21387_CR4","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","volume":"114","author":"DN Louis","year":"2007","unstructured":"Louis, D. N. et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 114, 97\u2013109 (2007).","journal-title":"Acta Neuropathol."},{"key":"21387_CR5","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1097\/00000478-199712000-00008","volume":"21","author":"A Perry","year":"1997","unstructured":"Perry, A., Stafford, S. L., Scheithauer, B. W., Suman, V. J. & Lohse, C. M. Meningioma grading: an analysis of histologic parameters. Am. J. Surg. Pathol. 21, 1455\u20131465 (1997).","journal-title":"Am. J. Surg. Pathol."},{"key":"21387_CR6","doi-asserted-by":"crossref","unstructured":"Saraf, S., McCarthy, B. J. & Villano, J. L. Update on meningiomas.Oncologist  16, 1604\u20131613 (2011).","DOI":"10.1634\/theoncologist.2011-0193"},{"key":"21387_CR7","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1093\/jnen\/63.4.275","volume":"63","author":"K Lamszus","year":"2004","unstructured":"Lamszus, K. Meningioma pathology, genetics, and biology. J. Neuropathol. Exp. Neurol. 63, 275\u2013286 (2004).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"21387_CR8","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s10143-023-01969-7","volume":"46","author":"F Gagliardi","year":"2023","unstructured":"Gagliardi, F. et al. Efficacy of radiotherapy and stereotactic radiosurgery as adjuvant or salvage treatment in atypical and anaplastic (WHO grade II and III) meningiomas: a systematic review and meta-analysis. Neurosurg. Rev. 46, 71 (2023).","journal-title":"Neurosurg. Rev."},{"key":"21387_CR9","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1136\/jnnp.2007.121582","volume":"79","author":"SY Yang","year":"2008","unstructured":"Yang, S. Y. et al. Atypical and anaplastic meningiomas: prognostic implications of clinicopathological features. J. Neurol. Neurosurg. Psychiatry. 79, 574\u2013580 (2008).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"21387_CR10","doi-asserted-by":"publisher","first-page":"291","DOI":"10.5414\/NP300408","volume":"30","author":"F Rogerio","year":"2011","unstructured":"Rogerio, F., de Araujo Zanardi, V., Ribeiro de Menezes Netto, J. & de Souza Queiroz, L. Meningioma with rhabdoid, papillary and clear cell features: case report and review of association of rare meningioma variants. Clin. Neuropathol. 30, 291\u2013296 (2011).","journal-title":"Clin. Neuropathol."},{"key":"21387_CR11","first-page":"2046","volume":"85","author":"A Perry","year":"1999","unstructured":"Perry, A., Scheithauer, B. W., Stafford, S. L., Lohse, C. M. & Wollan, P. C. Malignancy in meningiomas: a clinicopathologic study of 116 patients, with grading implications. Cancer 85, 2046\u20132056 (1999).","journal-title":"Cancer"},{"key":"21387_CR12","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.nec.2015.11.002","volume":"27","author":"M Karsy","year":"2016","unstructured":"Karsy, M., Guan, J., Cohen, A., Colman, H. & Jensen, R. L. Medical management of meningiomas: current Status, failed Treatments, and promising horizons. Neurosurg. Clin. N Am. 27, 249\u2013260 (2016).","journal-title":"Neurosurg. Clin. N Am."},{"key":"21387_CR13","doi-asserted-by":"publisher","first-page":"E18","DOI":"10.3171\/2013.10.FOCUS13341","volume":"35","author":"AA Moazzam","year":"2013","unstructured":"Moazzam, A. A., Wagle, N. & Zada, G. Recent developments in chemotherapy for meningiomas: a review. Neurosurg. Focus. 35, E18 (2013).","journal-title":"Neurosurg. Focus"},{"key":"21387_CR14","doi-asserted-by":"publisher","first-page":"90996","DOI":"10.18632\/oncotarget.18827","volume":"8","author":"H Takeda","year":"2017","unstructured":"Takeda, H. et al. Antitumor activity of gemcitabine against high-grade meningioma in vitro and in vivo. Oncotarget 8, 90996\u201391008 (2017).","journal-title":"Oncotarget"},{"key":"21387_CR15","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.neuchi.2016.02.003","volume":"62","author":"M Messerer","year":"2016","unstructured":"Messerer, M. et al. Recent advances in the management of atypical meningiomas. Neurochirurgie 62, 213\u2013222 (2016).","journal-title":"Neurochirurgie"},{"key":"21387_CR16","unstructured":"National Cancer Institute. Overview of the SEER Program.  https:\/\/seer.cancer.gov\/about\/overview.html"},{"key":"21387_CR17","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41746-020-0219-5","volume":"3","author":"JT Moreau","year":"2020","unstructured":"Moreau, J. T., Hankinson, T. C., Baillet, S. & Dudley, R. W. R. Individual-patient prediction of meningioma malignancy and survival using the Surveillance, Epidemiology, and end results database. NPJ Digit. Med. 3, 12 (2020).","journal-title":"NPJ Digit. Med."},{"key":"21387_CR18","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.3389\/fonc.2020.01021","volume":"10","author":"Y Jing","year":"2020","unstructured":"Jing, Y. et al. Development and validation of a prognostic nomogram to predict Cancer-Specific survival in adult patients with Pineoblastoma. Front. Oncol. 10, 1021 (2020).","journal-title":"Front. Oncol."},{"key":"21387_CR19","doi-asserted-by":"publisher","first-page":"e173","DOI":"10.1016\/S1470-2045(14)71116-7","volume":"16","author":"VP Balachandran","year":"2015","unstructured":"Balachandran, V. P., Gonen, M., Smith, J. J. & DeMatteo, R. P. Nomograms in oncology: more than Meets the eye. Lancet Oncol. 16, e173\u2013180 (2015).","journal-title":"Lancet Oncol."},{"key":"21387_CR20","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1148\/radiology.143.1.7063747","volume":"143","author":"JA Hanley","year":"1982","unstructured":"Hanley, J. A. & McNeil, B. J. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143, 29\u201336 (1982).","journal-title":"Radiology"},{"key":"21387_CR21","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1097\/EDE.0b013e3181a39056","volume":"20","author":"M Wolbers","year":"2009","unstructured":"Wolbers, M., Koller, M. T., Witteman, J. C. & Steyerberg, E. W. Prognostic models with competing risks: methods and application to coronary risk prediction. Epidemiology 20, 555\u2013561 (2009).","journal-title":"Epidemiology"},{"key":"21387_CR22","doi-asserted-by":"publisher","first-page":"2800","DOI":"10.1200\/JCO.2008.19.7418","volume":"27","author":"C Coutant","year":"2009","unstructured":"Coutant, C. et al. Comparison of models to predict nonsentinel lymph node status in breast cancer patients with metastatic Sentinel lymph nodes: a prospective multicenter study. J. Clin. Oncol. 27, 2800\u20132808 (2009).","journal-title":"J. Clin. Oncol."},{"key":"21387_CR23","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1177\/0272989X06295361","volume":"26","author":"AJ Vickers","year":"2006","unstructured":"Vickers, A. J. & Elkin, E. B. Decision curve analysis: a novel method for evaluating prediction models. Med. Decis. Mak. 26, 565\u2013574 (2006).","journal-title":"Med. Decis. Mak."},{"key":"21387_CR24","doi-asserted-by":"publisher","first-page":"7252","DOI":"10.1158\/1078-0432.CCR-04-0713","volume":"10","author":"RL Camp","year":"2004","unstructured":"Camp, R. L., Dolled-Filhart, M. & Rimm, D. L. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin. Cancer Res. 10, 7252\u20137259 (2004).","journal-title":"Clin. Cancer Res."},{"key":"21387_CR25","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1177\/0962280216666564","volume":"27","author":"M Resche-Rigon","year":"2018","unstructured":"Resche-Rigon, M. & White, I. R. Multiple imputation by chained equations for systematically and sporadically missing multilevel data. Stat. Methods Med. Res. 27, 1634\u20131649 (2018).","journal-title":"Stat. Methods Med. Res."},{"issue":"1","key":"21387_CR26","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/ehf2.13073","volume":"8","author":"S Shin","year":"2021","unstructured":"Shin, S. et al. Machine learning vs. conventional statistical models for predicting heart failure readmission and mortality. ESC Heart Fail. 8 (1), 106\u2013115 (2021).","journal-title":"ESC Heart Fail."},{"issue":"3","key":"21387_CR27","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1007\/s00357-019-09345-1","volume":"37","author":"J Muschelli","year":"2020","unstructured":"Muschelli, J. ROC and AUC with a binary predictor: a potentially misleading metric. J. Classif. 37 (3), 696\u2013708 (2020).","journal-title":"J. Classif."},{"issue":"20","key":"21387_CR28","doi-asserted-by":"publisher","first-page":"3449","DOI":"10.1002\/sim.5777","volume":"32","author":"H Ma","year":"2013","unstructured":"Ma, H., Bandos, A. I., Rockette, H. E. & Gur, D. On use of partial area under the ROC curve for evaluation of diagnostic performance. Stat. Med. 32 (20), 3449\u20133458 (2013).","journal-title":"Stat. Med."},{"key":"21387_CR29","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s11060-010-0342-2","volume":"99","author":"C Mawrin","year":"2010","unstructured":"Mawrin, C. & Perry, A. Pathological classification and molecular genetics of meningiomas. J. Neurooncol. 99, 379\u2013391 (2010).","journal-title":"J. Neurooncol"},{"key":"21387_CR30","doi-asserted-by":"publisher","first-page":"E3","DOI":"10.3171\/FOC-07\/10\/E3","volume":"23","author":"DL Commins","year":"2007","unstructured":"Commins, D. L., Atkinson, R. D. & Burnett, M. E. Review of meningioma histopathology. Neurosurg. Focus. 23, E3 (2007).","journal-title":"Neurosurg. Focus"},{"key":"21387_CR31","doi-asserted-by":"publisher","first-page":"719974","DOI":"10.3389\/fonc.2021.719974","volume":"11","author":"Z Jia","year":"2021","unstructured":"Jia, Z. et al. Development and validation of prognostic nomogram in patients with WHO grade III meningioma: A retrospective cohort study based on SEER database. Front. Oncol. 11, 719974 (2021).","journal-title":"Front. Oncol."},{"issue":"8","key":"21387_CR32","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1093\/neuonc\/nov069","volume":"17","author":"VR Kshettry","year":"2015","unstructured":"Kshettry, V. R. et al. Descriptive epidemiology of world health organization grades II and III intracranial meningiomas in the united States. Neuro Oncol. 17 (8), 1166\u20131173 (2015).","journal-title":"Neuro Oncol."},{"key":"21387_CR33","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1146\/annurev-med-042909-093756","volume":"62","author":"SG Deeks","year":"2011","unstructured":"Deeks, S. G. HIV infection, inflammation, immunosenescence, and aging. Annu. Rev. Med. 62, 141\u2013155 (2011).","journal-title":"Annu. Rev. Med."},{"key":"21387_CR34","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1016\/j.amepre.2013.10.029","volume":"46","author":"MC White","year":"2014","unstructured":"White, M. C. et al. Age and cancer risk: a potentially modifiable relationship. Am. J. Prev. Med. 46, S7\u201315 (2014).","journal-title":"Am. J. Prev. Med."},{"key":"21387_CR35","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.ijrobp.2007.12.020","volume":"71","author":"D Pasquier","year":"2008","unstructured":"Pasquier, D. et al. Mirimanoff RO and rare cancer N. Atypical and malignant meningioma: outcome and prognostic factors in 119 irradiated patients. A multicenter, retrospective study of the rare cancer network. Int. J. Radiat. Oncol. Biol. Phys. 71, 1388\u20131393 (2008).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"21387_CR36","doi-asserted-by":"publisher","first-page":"676683","DOI":"10.3389\/fonc.2021.676683","volume":"11","author":"GJ Zhang","year":"2021","unstructured":"Zhang, G. J., Liu, X. Y. & You, C. Clinical factors and outcomes of atypical meningioma: A Population-Based study. Front. Oncol. 11, 676683 (2021).","journal-title":"Front. Oncol."},{"key":"21387_CR37","doi-asserted-by":"publisher","first-page":"35743","DOI":"10.1038\/srep35743","volume":"6","author":"YC Wang","year":"2016","unstructured":"Wang, Y. C. et al. Long term surgical outcome and prognostic factors of atypical and malignant meningiomas. Sci. Rep. 6, 35743 (2016).","journal-title":"Sci. Rep."},{"key":"21387_CR38","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1093\/neuonc\/nov069","volume":"17","author":"VR Kshettry","year":"2015","unstructured":"Kshettry, V. R. et al. Descriptive epidemiology of world health organization grades II and III intracranial meningiomas in the united States. Neuro Oncol. 17, 1166\u20131173 (2015).","journal-title":"Neuro Oncol."},{"key":"21387_CR39","doi-asserted-by":"publisher","first-page":"932","DOI":"10.3171\/jns.2000.93.6.0932","volume":"93","author":"BP McKinley","year":"2000","unstructured":"McKinley, B. P., Michalek, A. M., Fenstermaker, R. A. & Plunkett, R. J. The impact of age and sex on the incidence of glial tumors in new York state from 1976 to 1995. J. Neurosurg. 93, 932\u2013939 (2000).","journal-title":"J. Neurosurg."},{"key":"21387_CR40","doi-asserted-by":"publisher","first-page":"eabq2630","DOI":"10.1126\/sciimmunol.abq2630","volume":"7","author":"H Kwon","year":"2022","unstructured":"Kwon, H. et al. Androgen conspires with the CD8(+) T cell exhaustion program and contributes to sex bias in cancer. Sci. Immunol. 7, eabq2630 (2022).","journal-title":"Sci. Immunol."},{"key":"21387_CR41","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1158\/2159-8290.CD-22-0869","volume":"13","author":"J Lee","year":"2023","unstructured":"Lee, J. et al. Sex-Biased T-cell exhaustion drives differential immune responses in glioblastoma. Cancer Discov. 13, 2090\u20132105 (2023).","journal-title":"Cancer Discov"},{"key":"21387_CR42","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1200\/jco.2015.33.28_suppl.81","volume":"33","author":"H-S Han","year":"2015","unstructured":"Han, H-S. et al. Comparison of prognosis and specific features according to tumor size in small-sized breast cancer with extensive lymph node involvement. J. Clin. Oncol. 33, 81\u201381 (2015).","journal-title":"J. Clin. Oncol."},{"key":"21387_CR43","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1148\/rg.2018180047","volume":"38","author":"N Tirada","year":"2018","unstructured":"Tirada, N. et al. Breast cancer tissue Markers, genomic Profiling, and other prognostic factors: A primer for radiologists. Radiographics 38, 1902\u20131920 (2018).","journal-title":"Radiographics"},{"key":"21387_CR44","first-page":"1082","volume":"3","author":"Y Dittmar","year":"2016","unstructured":"Dittmar, Y. et al. The impact of tumor size on the prognosis of gastric cancer: experiences from a European study group. J. Surg. 3, 1082 (2016).","journal-title":"J. Surg."},{"key":"21387_CR45","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1093\/annonc\/mdq321","volume":"22","author":"JY Park","year":"2011","unstructured":"Park, J. Y. et al. Outcomes after radical hysterectomy according to tumor size divided by 2-cm interval in patients with early cervical cancer. Ann. Oncol. 22, 59\u201367 (2011).","journal-title":"Ann. Oncol."},{"key":"21387_CR46","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s11060-022-04085-6","volume":"160","author":"MJ Recker","year":"2022","unstructured":"Recker, M. J., Kuo, C. C., Prasad, D., Attwood, K. & Plunkett, R. J. Incidence trends and survival analysis of atypical meningiomas: a population-based study from 2004 to 2018. J. Neurooncol. 160, 13\u201322 (2022).","journal-title":"J. Neurooncol"},{"key":"21387_CR47","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis, D. N. et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol. 23, 1231\u20131251 (2021).","journal-title":"Neuro Oncol."},{"key":"21387_CR48","doi-asserted-by":"publisher","first-page":"4376","DOI":"10.1002\/cncr.29639","volume":"121","author":"AA Aizer","year":"2015","unstructured":"Aizer, A. A. et al. Extent of resection and overall survival for patients with atypical and malignant meningioma. Cancer 121, 4376\u20134381 (2015).","journal-title":"Cancer"},{"key":"21387_CR49","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1002\/cncr.31088","volume":"124","author":"NR Rydzewski","year":"2018","unstructured":"Rydzewski, N. R. et al. Gross total resection and adjuvant radiotherapy most significant predictors of improved survival in patients with atypical meningioma. Cancer 124, 734\u2013742 (2018).","journal-title":"Cancer"},{"key":"21387_CR50","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1093\/neuros\/nyx312","volume":"82","author":"MO Chohan","year":"2018","unstructured":"Chohan, M. O. et al. Predictors of treatment response and survival outcomes in meningioma recurrence with atypical or anaplastic histology. Neurosurgery 82, 824\u2013832 (2018).","journal-title":"Neurosurgery"},{"key":"21387_CR51","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3171\/2010.1.JNS091114","volume":"113","author":"ME Sughrue","year":"2010","unstructured":"Sughrue, M. E. et al. Outcome and survival following primary and repeat surgery for world health organization grade III meningiomas. J. Neurosurg. 113, 202\u2013209 (2010).","journal-title":"J. Neurosurg."},{"key":"21387_CR52","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.ijrobp.2020.03.041","volume":"107","author":"M Terlizzi","year":"2020","unstructured":"Terlizzi, M. et al. Postoperative radiation therapy in patients with extracranial chondrosarcoma: A joint study of the French sarcoma group and rare cancer network. Int. J. Radiat. Oncol. Biol. Phys. 107, 726\u2013735 (2020).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"21387_CR53","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.radonc.2017.12.028","volume":"127","author":"B Atalar","year":"2018","unstructured":"Atalar, B. et al. Treatment outcome and prognostic factors for adult patients with medulloblastoma: the rare cancer network (RCN) experience. Radiother Oncol. 127, 96\u2013102 (2018).","journal-title":"Radiother Oncol."},{"key":"21387_CR54","doi-asserted-by":"publisher","first-page":"E3","DOI":"10.3171\/2019.3.FOCUS1971","volume":"46","author":"AK Reddy","year":"2019","unstructured":"Reddy, A. K., Ryoo, J. S., Denyer, S., McGuire, L. S. & Mehta, A. I. Determining the role of adjuvant radiotherapy in the management of meningioma: a Surveillance, Epidemiology, and end results analysis. Neurosurg. Focus. 46, E3 (2019).","journal-title":"Neurosurg. Focus"},{"key":"21387_CR55","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s11060-013-1239-7","volume":"115","author":"B Detti","year":"2013","unstructured":"Detti, B. et al. Atypical and malignant meningioma: outcome and prognostic factors in 68 irradiated patients. J. Neurooncol. 115, 421\u2013427 (2013).","journal-title":"J. Neurooncol"},{"key":"21387_CR56","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/cam4.1531","volume":"8","author":"H Zhu","year":"2019","unstructured":"Zhu, H. et al. Efficacy of adjuvant radiotherapy for atypical and anaplastic meningioma. Cancer Med. 8, 13\u201320 (2019).","journal-title":"Cancer Med."},{"key":"21387_CR57","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1093\/neuonc\/nou025","volume":"16","author":"G Kaur","year":"2014","unstructured":"Kaur, G. et al. James CD and Parsa AT. Adjuvant radiotherapy for atypical and malignant meningiomas: a systematic review. Neuro Oncol. 16, 628\u2013636 (2014).","journal-title":"Neuro Oncol."},{"key":"21387_CR58","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.radonc.2018.06.018","volume":"128","author":"DC Weber","year":"2018","unstructured":"Weber, D. C. et al. Adjuvant postoperative high-dose radiotherapy for atypical and malignant meningioma: A phase-II parallel non-randomized and observation study (EORTC 22042\u201326042). Radiother Oncol. 128, 260\u2013265 (2018).","journal-title":"Radiother Oncol."},{"issue":"1","key":"21387_CR59","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s00280-015-2927-0","volume":"77","author":"E Mazza","year":"2016","unstructured":"Mazza, E. et al. Hydroxyurea with or without Imatinib in the treatment of recurrent or progressive meningiomas: a randomized phase II trial by gruppo Italiano cooperativo Di Neuro-Oncologia (GICNO). Cancer Chemother. Pharmacol. 77 (1), 115\u2013120 (2016).","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"2","key":"21387_CR60","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3390\/cancers15020483","volume":"15","author":"A Shahbandi","year":"2023","unstructured":"Shahbandi, A., Shah, D. S., Hadley, C. C. & Patel, A. J. The role of pharmacotherapy in treatment of meningioma: A systematic review. Cancers (Basel). 15 (2), 483 (2023).","journal-title":"Cancers (Basel)"},{"key":"21387_CR61","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s11060-020-03455-2","volume":"147","author":"HP Bhambhvani","year":"2020","unstructured":"Bhambhvani, H. P., Rodrigues, A. J., Medress, Z. A. & Hayden Gephart, M. Racial and socioeconomic correlates of treatment and survival among patients with meningioma: a population-based study. J. Neurooncol. 147, 495\u2013501 (2020).","journal-title":"J. Neurooncol"},{"key":"21387_CR62","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1080\/00207454.2020.1818742","volume":"132","author":"R Brewster","year":"2022","unstructured":"Brewster, R. et al. The effect of socioeconomic status on age at diagnosis and overall survival in patients with intracranial meningioma. Int. J. Neurosci. 132, 413\u2013420 (2022).","journal-title":"Int. J. Neurosci."},{"issue":"6","key":"21387_CR63","doi-asserted-by":"publisher","first-page":"E18","DOI":"10.3171\/2013.10.FOCUS13341","volume":"35","author":"AA Moazzam","year":"2013","unstructured":"Moazzam, A. A., Wagle, N. & Zada, G. Recent developments in chemotherapy for meningiomas: a review. Neurosurg. Focus. 35 (6), E18 (2013).","journal-title":"Neurosurg. Focus"},{"key":"21387_CR64","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1093\/neuonc\/noy162","volume":"21","author":"RL Achey","year":"2019","unstructured":"Achey, R. L. et al. Nonmalignant and malignant meningioma incidence and survival in the elderly, 2005\u20132015, using the central brain tumor registry of the united States. Neuro Oncol. 21, 380\u2013391 (2019).","journal-title":"Neuro Oncol."},{"key":"21387_CR65","doi-asserted-by":"publisher","first-page":"e361","DOI":"10.1016\/j.wneu.2020.02.120","volume":"138","author":"T Elder","year":"2020","unstructured":"Elder, T. et al. Association of race with survival in intracranial world health organization grade II and III meningioma in the united States. Syst. Literature Rev. World Neurosurg. 138, e361\u2013e369 (2020).","journal-title":"Syst. Literature Rev. World Neurosurg."},{"key":"21387_CR66","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.1097\/MLR.0000000000000073","volume":"54","author":"AM Noone","year":"2016","unstructured":"Noone, A. M. et al. Comparison of SEER treatment data with medicare claims. Med. Care. 54, e55\u201364 (2016).","journal-title":"Med. Care"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21387-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21387-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21387-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T02:03:15Z","timestamp":1761962595000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21387-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,27]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["21387"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-21387-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,27]]},"assertion":[{"value":"10 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All authors signed the SEER Research Data Agreement to protect patient privacy, ensuring that all data used in the study comply with the ethical principles outlined in the agreement. The SEER database is a publicly accessible de-identified dataset, and the use of its data for research purposes is approved by the National Cancer Institute under the SEER program. Given the anonymized nature of SEER data, informed consent is not required for its use in research. For the external validation cohort, all data collection was approved by the Ethics Committee of the First Affiliated Hospital of Fujian Medical University (protocol number: [2024]117]). Informed consent was obtained from all patients prior to inclusion in the study. Data from the external cohort were collected retrospectively and anonymized to ensure patient confidentiality during data linkage with the SEER dataset. Ethical oversight was maintained throughout the study, with adherence to all local and international ethical guidelines for the protection of human participants in medical research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}],"article-number":"37475"}}